Q: tiny cap i am reviewing would like your opinion.
5i Research Answer:
Microbix is a biotech company focused on medical devices and diagnostics. It is small at a $33 mln market-cap and is down 30% this year. Revenue has larely been flat since 2021. The company has $9.1 mln in cash as of the recent quarter and roughly $5 mln in debt. We would prefer to see a bit better stock and revenue momentum before getting too interested here.